Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ali Abdulsahib"'
Autor:
Al-Butahi, Ali Abdulsahib1, Al-Bayati, Salam Adel1 salam.adel@nahrainuniv.edu.iq
Publikováno v:
Iraqi Journal of Science. 2023, Vol. 64 Issue 5, p2391-2404. 14p.
Outcome of imatinib mesylate in women with child-bearing age diagnosed with chronic myeloid leukemia
Publikováno v:
Iraqi Journal of Hematology, Vol 10, Iss 2, Pp 123-126 (2021)
BACKGROUND: Imatinib Mesylate (IM) is an oral tyrosine kinase inhibitor, which demonstrates great effect in the treatment of both chronic myeloid leukemia (CML) and gastrointestinal stromal tumors. The effects of this chemotherapeutic drug on women w
Externí odkaz:
https://doaj.org/article/87b6fedcc1b54ace825608870b8c1e32
Publikováno v:
AIP Conference Proceedings; 2024, Vol. 2922 Issue 1, p1-9, 9p
Publikováno v:
Journal of the College Of Basic Education; Feb2024, Vol. 30 Issue 123, p14-28, 15p
Autor:
Alaa Fadhil Alwan, Manal Ali Abdulsahib, Duaa Dhahir Abbas, Saraa Ali Abdulsattar, Reem Talib Ensaif
Publikováno v:
Hematology Reports, Vol 12, Iss 3 (2020)
Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin Lymphoma (NHL) are considered parts of mature B cell neoplasms in WHO classification. They are both characterized by accumulation of B cells in blood, lymphoid tissues and bone marrow. Most of treatm
Externí odkaz:
https://doaj.org/article/58a7b2a48b574d62a00734121673f8e7
Publikováno v:
Cureus.
Publikováno v:
Cureus.
Publikováno v:
Cureus.
Publikováno v:
Cureus.
Publikováno v:
Cureus.